TNF-α is a therapeutic target for inflammatory illnesses such as rheumatoid arthritis, Crohn’s disease, atherosclerosis, sepsis, and obesity [46]. The gene discussed is TNF; the disease is obesity due to melanocortin 4 receptor deficiency.